Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Reprod Biomed Online ; 47(5): 103338, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37757612

RESUMEN

The Internet of Things (IoT) is a network connecting physical objects with sensors, software and internet connectivity for data exchange. Integrating the IoT with medical devices shows promise in healthcare, particularly in IVF laboratories. By leveraging telecommunications, cybersecurity, data management and intelligent systems, the IoT can enable a data-driven laboratory with automation, improved conditions, personalized treatment and efficient workflows. The integration of 5G technology ensures fast and reliable connectivity for real-time data transmission, while blockchain technology secures patient data. Fog computing reduces latency and enables real-time analytics. Microelectromechanical systems enable wearable IoT and miniaturized monitoring devices for tracking IVF processes. However, challenges such as security risks and network issues must be addressed through cybersecurity measures and networking advancements. Clinical embryologists should maintain their expertise and knowledge for safety and oversight, even with IoT in the IVF laboratory.


Asunto(s)
Internet de las Cosas , Humanos , Internet , Automatización , Laboratorios , Reproducción
3.
Reprod Biomed Online ; 39(1): 63-74, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31126717

RESUMEN

RESEARCH QUESTION: Assisted reproduction laboratories record instrument performance periodically. No standardized guidelines have been produced for this activity despite mandatory auditing systems in several countries. This study of 36 laboratories in 12 different countries was conducted to assess differences and similarities between quality assurance programmes using an adaptable cloud-based quality-control app for instrument monitoring. DESIGN: A total of 36 deidentified IVF laboratories that subscribed to the same quality-assurance application were studied. Data were evaluated based on instrument types allocated to 10 domains: incubators, gas tanks, warming surfaces, refrigerators and freezers, cryo-storage, environment, water purification, peripheral equipment, checklists and miscellaneous. RESULTS: The incubator domain constituted the greatest proportion of parameters (35%), followed by surface warming instruments at 15%. Most incubator O2 readings were monitored between 4.5 and 5.5%, and between 5.5 and 6.5% for CO2. The altitude of the laboratory was poorly correlated with the CO2 setting. Incubator display and measured values of gases and temperature by built-in sensors vary considerably compared with third-party sensors. A quality-control diligence score or mean average data points was calculated for each laboratory. This score is independent of number of instruments or laboratory size. Higher scores were associated with laboratories in countries with government regulations and mandatory auditing systems. CONCLUSIONS: Major differences exist in instrument monitoring practices among laboratories. Although incubator monitoring is the largest domain, many other sensitive instruments are diligently monitored by most laboratories. International standardization and guidelines are needed.


Asunto(s)
Planificación Ambiental , Laboratorios , Control de Calidad , Técnicas Reproductivas Asistidas/instrumentación , Técnicas Reproductivas Asistidas/normas , Planificación Ambiental/normas , Análisis de Falla de Equipo , Femenino , Fertilización In Vitro/instrumentación , Fertilización In Vitro/normas , Humanos , Incubadoras/normas , Laboratorios/organización & administración , Laboratorios/normas , Ensayos de Aptitud de Laboratorios/métodos , Masculino , Embarazo , Garantía de la Calidad de Atención de Salud/métodos , Garantía de la Calidad de Atención de Salud/normas , Refrigeración/instrumentación , Refrigeración/normas
4.
Fertil Steril ; 91(3): 943-5, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17931632

RESUMEN

There is a known correlation between morphology and euploidy, but we believe that the association between the two embryo selection systems is too marginal to claim that it is absolute and that one can simply replace one system by the other. The optimal way to select euploid embryos is through a combination of morphology determination and preimplantation genetic diagnosis.


Asunto(s)
Aneuploidia , Transferencia de Embrión , Embrión de Mamíferos/patología , Pruebas Genéticas , Microscopía , Diagnóstico Preimplantación/métodos , Femenino , Humanos , Valor Predictivo de las Pruebas , Embarazo
5.
Hum Reprod ; 23(3): 499-503, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18182396

RESUMEN

BACKGROUND: The aim of this study was to evaluate the effect of ovarian stimulation with LH-containing gonadotropins (human menopausal gonadotropin, hMG), on ploidy of human cleavage-stage-embryos. METHODS: A total of 104 women, at ages 27-43 years, undergoing one cycle of controlled ovarian hyperstimulation for IVF in combination with preimplantation genetic diagnosis, were eligible for enrollment in this retrospective, controlled cohort study. Ovarian stimulation included down-regulation with long agonist and stimulation with either recombinant FSH or hMG. Since the ploidy of embryos changes with female age, patients were matched for age and dosage of the respective gonadotropin. RESULTS: Despite similar numbers of chromosomally normal embryos in both groups, women undergoing hMG stimulation demonstrated significantly higher percentages of diploid embryos than did the FSH-stimulated patients (69.8 versus 45.3%; P < 0.01). CONCLUSIONS: Long protocol LH-containing ovarian stimulation improves embryonic ploidy in comparison to pure FSH stimulation. This observation may explain higher IVF pregnancy rates, reported for hMG stimulation in some studies.


Asunto(s)
Blastocisto/citología , Diploidia , Hormona Folículo Estimulante/uso terapéutico , Menotropinas/uso terapéutico , Inducción de la Ovulación/métodos , Adulto , Femenino , Fertilización In Vitro , Humanos , Embarazo , Índice de Embarazo , Diagnóstico Preimplantación , Estudios Retrospectivos
6.
Kennedy Inst Ethics J ; 4(3): 193-203, 1994 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11645276

RESUMEN

Although many scientists view cloning as a useful procedure for scientific research into early embryo development -- one that cannot currently be used to produce multiple copies of humans -- the popular literature has led some individuals to view it as sinister. To address the concerns of the public, various conceptions of cloning are distinguished and their basis in fact analyzed. The possible uses, benefits, and detriments of both embryo splitting and nuclear transplantation are explained. Once the nature and purposes of cloning are understood, and the distinctive ethical dilemmas created by embryo splitting and nuclear transplantation are sorted out, these procedures should be clinically implemented to assist in vitro fertilization treatment for those who are infertile and to further other therapeutic and investigational efforts in medicine.


Asunto(s)
Clonación de Organismos , Investigaciones con Embriones , Embrión de Mamíferos , Métodos , Investigación , Medición de Riesgo , Riesgo , Experimentación Animal , Bienestar del Animal , Animales , Investigación Biomédica , Humanos , Literatura , Técnicas Reproductivas Asistidas , Ciencia , Terminología como Asunto , Gemelización Monocigótica , Gemelos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...